Clinical Trial Update: A Study of Safety, Tolerability, and Pk of rhMBL in Pediatric Hematology/Oncology Pts With Fever and Neutropenia [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety, tolerability, and pharmacokinetics of recombinant human mannose-binding lectin (rhMBL) in pediatric oncology/hematology patient…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Hematologic Disease
• Neutropenia

Drugs mentioned

• rhMBL (recombinant human mannose-binding lectin)

Snippet

Sponsor: Enzon Pharmaceuticals, Inc. | Conditions: Cancer, Hematologic Diseases | Phase 1 | Status: WITHDRAWN